Increased postpartum anxiety symptoms after perinatal SARS-CoV-2 infection in a large, prospective pregnancy cohort in New York City

• Published in: Journal of psychiatric research 2024-02, Vol.170, p.130-137
• Main Authors: Castro, Juliana, Gigase, Frederieke A.J., Molenaar, Nina M., Ibroçi, Erona, Perez-Rodriguez, M. Mercedes, Lieb, Whitney, Janevic, Teresa, de Witte, Lot D., Bergink, Veerle, Rommel, Anna-Sophie
• Format: Article
• Language: English
• Subjects: Anxiety - psychology; COVID-19 - complications; COVID-19 - epidemiology; COVID-19 pandemic; Depression - psychology; Depression, Postpartum - epidemiology; Depression, Postpartum - psychology; Female; Humans; New York City - epidemiology; Pandemics; Perinatal mental health; Postpartum anxiety; Postpartum depression; Postpartum Period - psychology; Pregnancy; Prenatal infection; Prospective Studies; SARS-CoV-2
• ISSN: 0022-3956; 1879-1379; 1879-1379
• DOI: 10.1016/j.jpsychires.2023.12.020

Numerous studies reported an increase of postpartum mood symptoms during the COVID-19 pandemic. Yet, the link between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and perinatal mental health is less well understood. We investigated the associations between prenatal SARS-CoV-2 infection and postpartum depressive and anxiety symptoms, including examinations of infection timing and pandemic timeline. We included 595 participants from Generation C, a prospective pregnancy cohort in New York City (2020–2022). Prenatal SARS-CoV-2 infection was determined via laboratory or medical diagnosis. Depression and anxiety symptoms were measured 4–12 weeks postpartum using the Edinburgh Postnatal Depression Scale (EPDS) and Generalized Anxiety Disorder questionnaire (GAD), respectively. Quantile regressions were conducted with prenatal SARS-CoV-2 infection as exposure and continuously measured EPDS and GAD scores as outcomes. We reran the analyses in those with COVID-19-like symptoms in the trimester during which infection occurred. 120 (20.1%) participants had prenatal SARS-CoV-2 infection. After adjusting for socio-demographic, obstetric and other maternal health factors, prenatal SARS-CoV-2 infection was associated with higher median postpartum anxiety scores (b = 0.55, 95% CI = 0.15; 0.96). Late gestation infection (b = 1.15, 95% CI = 0.22; 2.09) and symptomatic infection (b = 1.15, 95% CI = 0.12; 2.18) were also associated with higher median postpartum anxiety scores. No associations were found with depressive symptoms. The associations were not moderated by time since the start of the pandemic. This study suggests that prenatal SARS-CoV-2 infection increases the risk of postpartum anxiety symptoms among participants reporting median anxiety symptoms. Given that this association was not affected by pandemic timing and that SARS-CoV-2 transmission continues, individuals infected with SARS-CoV-2 during pregnancy should be monitored for postpartum anxiety symptoms. •Prenatal SARS-CoV-2 infection is associated with increased postpartum anxiety symptoms.•Prenatal SARS-CoV-2 infection is not associated with postpartum depressive symptoms.•Time between start pandemic and birth did not affect the association between infection and postpartum mood symptoms.